Clinical Trial Update: Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluation of SM88 in prostate cancer has completed Phase 1 and Phase 2, assessing efficacy, safety, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SM88

Snippet

Sponsor: Tyme, Inc | Conditions: Prostate Cancer, Rising Prostate Specific Antigen (PSA) | Phase 1, Phase 2 | Status: COMPLETED